Zobrazeno 101 - 110
of 138
pro vyhledávání: '"Ronjon Chakraverty"'
Autor:
M N Dimopoulou, Panos Kottaridis, Stephen Mackinnon, S Gandhi, D Webster, Cedric Ghevaert, Adele K. Fielding, Ronjon Chakraverty
Publikováno v:
Bone Marrow Transplantation. 40:605-606
Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion
Autor:
P. Stross, Christopher S. Garrard, Timothy Littlewood, Ronjon Chakraverty, KS Peggs, S. Davidson
Publikováno v:
British journal of haematology. 93(2)
We studied 235 patients admitted to an adult intensive care unit in order to determine the incidence and cause of coagulation disturbances, Clinical coagulopathy, defined as bleeding unexplained by local or surgical factors, was identified in 136% of
Autor:
Emma C. Morris, Hans J. Stauss, Ben Carpenter, Noha Edwards, Emma Nicholson, Ronjon Chakraverty, Sara Ghorashian, Angelika Holler, Barry Flutter, Jim E. Griffin, Maryam Ahmadi
Publikováno v:
Blood. 120:3009-3009
Abstract 3009 Background: Interactions between tumour cells and host cells within the microenvironment are important in promoting the development of cancer. Tumor niches provide crucial anti-apoptotic and anti-proliferative signals that drive tumor c
Autor:
Shao-An Xue, Barry Flutter, Ronjon Chakraverty, Sara Ghorashian, Graham P. Wright, Emma C. Morris, BJ Uttenthal, Emma Nicholson, Ben Carpenter
Publikováno v:
Blood. 120:3152-3152
Abstract 3152 Alloreactive immune responses directed against malignant cells in recipients of allogeneic hematopoietic stem cell transplants are able to cure patients with hematological cancers. However, such immune responses may cause severe morbidi
Autor:
Clare L. Bennett, Angelika Holler, Mathias Zech, Shao-An Xue, Emma C. Morris, Hans J. Stauss, Maryam Ahmadi, Ben Carpenter, Ronjon Chakraverty, Emma Nicholson, Sara Ghorashian
Publikováno v:
Blood. 120:952-952
Abstract 952 Background: The efficacy of T cell therapies for cancer may be limited when targeting tumour-associated antigens (TAA) which are also self-antigens. Ongoing exposure to TAA on normal cells may lead to tolerance via anergy or exhaustion o
Autor:
Emma Nicholson, Ronjon Chakraverty, Martin Pule, Shao-An Xue, Hans J. Stauss, Ben Carpenter, Jim E. Griffin
Publikováno v:
Blood. 120:3008-3008
Abstract 3008 In vivo selection of mycophenolate mofetil-resistant T cells for adoptive immunotherapy. Background Following allogeneic solid organ or hematopoietic stem cell transplantation, adoptive transfer of therapeutic T cells may be hindered by
Autor:
Michael Croft, Lei Zhang, Barry Flutter, Megan Sykes, Ronjon Chakraverty, Shivajanani Sivakumaran, Noha Edwards
Publikováno v:
Blood. 118:1911-1911
Abstract 1911 A major limitation of adoptive T cell therapies for cancer is the failure to maintain durable anti-tumor immunity. Graft-versus-tumor responses following bone marrow transplantation (BMT) may only be short-lived due to 1) defects in mem
Autor:
Kirsty Thomson, Emma C. Morris, Karl S. Peggs, Ronjon Chakraverty, Stephen Mackinnon, Rachael Hough, Anthony H. Goldstone, Kirit M. Ardeshna, Adele K. Fielding, Panagiotis D. Kottaridis, David C. Linch, Irfan Kayani
Publikováno v:
Blood. 118:2016-2016
Abstract 2016 Positron emission tomography (PET) scanning is increasingly recognised to provide important prognostic information in patients with Hodgkin Lymphoma (HL) receiving chemotherapy or undergoing autologous stem cell transplantation. Its rol
Autor:
Panos Kottaridis, Kirsty Thomson, Stephanie Verfuerth, Ronjon Chakraverty, Stephen Mackinnon, Emma C. Morris, Kirit M. Ardeshna, Karl S. Peggs, Noha Chowdhry, David C. Linch, Anthony H. Goldstone
Publikováno v:
Blood. 114:200-200
Abstract 200 The feasibility of performing allogeneic HSCT in patients with Hodgkin Lymphoma using reduced intensity conditioning (RIC) is well established. By reducing non-relapse mortality, these approaches have seemingly improved post-transplant s
Publikováno v:
Blood. 114:2450-2450
Abstract 2450 Poster Board II-427 Following allogeneic bone marrow transplantation (BMT), delayed donor leukocyte infusion (DLI) at a point when conditioning-induced inflammation has resolved, is employed to induce graft-versus-leukemia (GVL) respons